Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;14:413-420

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geisterfer, A. A.
Right arrow Articles by Owens, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geisterfer, A. A.
Right arrow Articles by Owens, G. K.

Hypertension, Vol 14, 413-420, Copyright © 1989 by American Heart Association


ARTICLES

Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells

AA Geisterfer and GK Owens
Department of Physiology University of Virginia, School of Medicine, Charlottesville 22908.

Recently we reported that the contractile agonist angiotensin II induces hypertrophy, not hyperplasia, in cultured rat aortic smooth muscle cells (Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-756). We have further explored the hypothesis that contractile agonists are important regulators of smooth muscle cell growth by examining the effects of another contractile agonist, arginine vasopressin, on growth of cultured rat aortic smooth muscle cells. Autoradiographic analysis as well as cell number determinations showed that arginine vasopressin (1 microM) did not stimulate proliferation in cells made quiescent in a defined serum-free media nor did it augment proliferation in 0.4% fetal bovine serum. However, flow cytometric analysis of cellular protein content demonstrated that arginine vasopressin (1 microM) did induce cellular hypertrophy in quiescent cultures after 4 days of treatment, increasing smooth muscle cell protein content by 35% as compared with vehicle- treated controls. The increase in protein content showed a concentration dependence. Cellular hypertrophy was accompanied by an increase in [35S]methionine incorporation, which was elevated 45% by 24 hours. Both the increase in [35S]methionine incorporation and the increase in protein content could be prevented by the specific arginine vasopressin receptor antagonist. [1-beta-mercapto-beta,beta- cyclopentamethylene propionic acid), 2-(O-methyl)tyrosine] arginine vasopressin. An increase in [35S]methionine incorporation was observed between 12 and 24 hours after treatment of quiescent smooth muscle cells for only 5 minutes with arginine vasopressin (1 microM). Arginine vasopressin-induced increases in [35S]methionine incorporation was increased within 6 hours after treatment. These studies show that arginine vasopressin, like angiotensin II, induces hypertrophy but not hyperplasia of cultured rat aortic smooth muscle cells.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
O. Levy and Y. Granot
Arginine-Vasopressin Activates the JAK-STAT Pathway in Vascular Smooth Muscle Cells
J. Biol. Chem., June 9, 2006; 281(23): 15597 - 15604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Kaplan-Albuquerque, Y. E. Bogaert, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff
Patterns of Gene Expression Differentially Regulated by Platelet-derived Growth Factor and Hypertrophic Stimuli in Vascular Smooth Muscle Cells: MARKERS FOR PHENOTYPIC MODULATION AND RESPONSE TO INJURY
J. Biol. Chem., May 20, 2005; 280(20): 19966 - 19976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Kaplan-Albuquerque, C. Garat, V. Van Putten, and R. A. Nemenoff
Regulation of SM22{alpha} expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1444 - H1452.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. C. Berk
Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms
Physiol Rev, July 1, 2001; 81(3): 999 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Thibonnier, C. L. Plesnicher, K. Berrada, and L. Berti-Mattera
Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E81 - E92.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Chiarenza, A. Filippini, A. Tripiciano, E. Beccari, and F. Palombi
Platelet-Derived Growth Factor-BB Stimulates Hypertrophy of Peritubular Smooth Muscle Cells from Rat Testis in Primary Cultures
Endocrinology, August 1, 2000; 141(8): 2971 - 2981.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Y. Bogdanov, M. Poon, and M. B. Taubman
Platelet-derived Growth Factor-specific Regulation of the JE Promoter in Rat Aortic Smooth Muscle Cells
J. Biol. Chem., September 18, 1998; 273(38): 24932 - 24938.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Higashita, L. Li, V. Van Putten, Y. Yamamura, F. Zarinetchi, L. Heasley, and R. A. Nemenoff
Galpha 16 Mimics Vasoconstrictor Action to Induce Smooth Muscle alpha -Actin in Vascular Smooth Muscle Cells through a Jun-NH2-terminal Kinase-dependent Pathway
J. Biol. Chem., October 10, 1997; 272(41): 25845 - 25850.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S.-L. Lee, W.-W. Wang, P. M. Joseph, C. A. Hales, and B. L. Fanburg
Inhibitory Effect of Heparin on Serotonin-induced Hyperplasia and Hypertrophy of Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., July 1, 1997; 17(1): 78 - 83.
[Abstract] [Full Text]


Home page
HypertensionHome page
L. M. Burrell, P. A. Phillips, J. Risvanis, K. L. Aldred, A.-M. Hutchins, and C. I. Johnston
Attenuation of Genetic Hypertension After Short-term Vasopressin V1A Receptor Antagonism
Hypertension, November 1, 1995; 26(5): 828 - 834.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. F. Patton, H. Erdjument-Bromage, A. R. Marks, P. Tempst, and M. B. Taubman
Components of the Protein Synthesis and Folding Machinery Are Induced in Vascular Smooth Muscle Cells by Hypertrophic and Hyperplastic Agents
J. Biol. Chem., September 8, 1995; 270(36): 21404 - 21410.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Simon and B. G. Kasson
Identification of Vasopressin mRNA in Rat Aorta
Hypertension, May 1, 1995; 25(5): 1030 - 1033.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Garat, V. Van Putten, Z. A. Refaat, C. Dessev, S.-Y. Han, and R. A. Nemenoff
Induction of Smooth Muscle alpha -Actin in Vascular Smooth Muscle Cells by Arginine Vasopressin Is Mediated by c-Jun Amino-terminal Kinases and p38 Mitogen-activated Protein Kinase
J. Biol. Chem., July 14, 2000; 275(29): 22537 - 22543.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. P. Reusch, M. Schaefer, C. Plum, G. Schultz, and M. Paul
Gbeta gamma Mediate Differentiation of Vascular Smooth Muscle Cells
J. Biol. Chem., May 25, 2001; 276(22): 19540 - 19547.
[Abstract] [Full Text] [PDF]